Bearish flow noted in Immunovant with 1,793 puts trading, or 1.5x expected. Most active are Oct-23 15 puts and Oct-23 35 calls, with total volume in those strikes near 740 contracts. The Put/Call Ratio is 2.65, while ATM IV is up over 10 points on the day. Earnings are expected on November 3rd.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IMVT:
- Immunovant put volume heavy and directionally bearish
- Immunovant CEO sells $2.2M in common stock
- Immunovant price target raised to $33 from $28 at Citi
- Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2023
- Immunovant reports Q1 EPS (57c), consensus (45c)
